Retinoids for preventing the progression of cervical intraepithelial neoplasia

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Helm, C William ^a   Lorenz, D J ^b   Meyer, N J ^b   Rising, W R ^b   Wulff, J L ^b  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Anticarcinogenic agents *therapeutic use ; Cervical intraepithelial neoplasia *drug therapy ; Disease progression; Female; Humans; Randomized controlled trials as topic; Retinoids; Uterine cervical neoplasms *drug therapy

Indexed keywords

ALIRETINOIN; FENRETINIDE; ISOTRETINOIN; PLACEBO; RETINOID; RETINOL;

BURNING SENSATION; CANCER DIAGNOSIS; CANCER PREVENTION; CELL GROWTH; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG INTOXICATION; DRUG MEGADOSE; DRUG WITHDRAWAL; DRY EYE; DRY SKIN; EPITHELIUM CELL; HAIR DISEASE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; IRRITANT DERMATITIS; LOW DRUG DOSE; NONHUMAN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 44949179989     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003296.pub2     Document Type: Review

References (53)

1. Alvarez 2003 {published data only} Alvarez RD, Conner MG, Weiss H, Klug PM, Niwas S, Manne U, et al.The efficacy of 9-cis retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: Results of a randomized double blind clinical trial. Cancer, Epidemiology, Biomarkers & Prevention 2003;12(2):114-9. [MEDLINE: 12582020].
2. Follen 2001 {published data only} Follen M, Atkinson EN, Schottenfeld D, Malpica A, West L, Lippman S, et al.A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clinical Cancer Research 2001;7(11):3356-65. [MEDLINE: 11705848].
3. Meyskens 1994 {published data only} Meyskens FL, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, et al.Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. Journal of the National Cancer Institute 1994;86 (7):539-43. [MEDLINE: 8133537].
4. Robinson 2002 {published data only} Robinson WR, Andersen J, Darragh TM, Kendall MA, Clark R, Maiman M. Isotretinoin for low-grade cervical dysplasia in human immunodeficiency virus-infected women. Obstetrics and Gynecology 2002;99(5):777-84. [MEDLINE: 11978287].
5. Ruffin 2004 {published data only} Ruffin MT, Bailey JM, Normolle DP, Michael CW, Bieniasz ME, Kmak DC, et al.Low-dose topical delivery of All-trans retinoic acid for cervical intraepithelial neoplasia II and III. Cancer, Epidemiology, Biomarkers & Prevention 2004;13(12): 2148-52. [MEDLINE: 15598773].
6. Ahn 1997 Ahn WS, Lee JM, Namkoong SE, Lee HY, Kim SJ. Effect of retinoic acid on HPV titration and colposcopic changes in Korean patients with dysplasia of the uterine cervix. Journal of Cellular Biochemistry 1997;67 (Suppl 28/29):133-139. [MEDLINE: 9589358].
7. Chen 1987 Chen RD, Wang RZ, Luo HZ, Liu Y, Bao PY, Li XL, et al.Chemoprevention of cancer of the uterine cervix - preliminary study on the intervention of the cervical precancerous lesion by retinamide RII. Chung-Hua Chung Liu Tsa Chih 1987;9(5):348-50. [MEDLINE: 3452524].
8. Chen 1994 Chen RD, Ding AH, Han R, Luo HZ, Fei LF, Sun SF, et al.A study on chemoprevention of retinamide II for cervical precancerous lesions. Chung-Hua Yu Fang i Hsueh Tsa Chih 1994;28(5):75-7. [MEDLINE: 7924650].
9. Comerci 1997 Comerci JT, Runowicz CD, Fields AL, Romney SL, Palan PR, Kadish AS, et al.Induction of transforming growth factor beta-1in cervical intraepithelial neoplasia in vivo after treatment with beta-carotene. Clinical Cancer Research 1997;3(2):157-60. [MEDLINE: 9815667].
10. DiSilvestro 2001 DiSilvestro PA, DiSilvestro JM, Lernhardt W, Pfahl M, Mannel RS. Treatment of Cervical Intraepithelial Neoplasia levels 2 and 3 with adapalene, a Retinoid-related molecule. Journal of Lower Genital Tract Disease 2001;5(1):33-7.
11. Graham 1986 Graham V, Surwit ES, Weiner S, Meyskens FL Jr. Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. Western Journal of Medicine 1986;145(2):192-5. [MEDLINE: 3765597].
12. Han 1990 Han J, Jiao L, Lu Y, Sun Z, Gu QM, Scanlon KJ. Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent. In Vivo 1990;4(3):153-60. [MEDLINE: 2133256].
13. Han 1993 Han J. Highlights of the cancer chemoprevention studies in China. Preventive Medicine 1993;22(5):712-22.
14. Kelloff 1995 Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk E, Steele VE, et al.Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary. Journal of Cellular Biochemistry 1995;23 (Suppl):1-9. [MEDLINE: 8747372].
15. Kim 2005 Kim HG, Yamal JM, Xu XC, Hu W, Boiko I, Linares A, et al.Cervical chromosome 9 polysomy: Validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trial. Gynecologic Oncology 2005;99(3 (suppl 1)):S32-7. [MEDLINE: 16154183].
16. Meyskens 1983 Meyskens FL, Graham V, Chvapil M, Dorr RT, Alberts DS, Surwit EA. A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia. Journal of the National Cancer Institute 1983;71 (5):921-5. [MEDLINE: 6580493].
17. Meyskens 1986 Meyskens FL Jr, Surwit ES. Clinical experience with topical tretinoin in the treatment of cervical dysplasia. Journal of the American Academy of Dermatology 1986;15(4 part 2):826-9. [MEDLINE: 3534021].
18. Mitchell 1995 Mitchell MF, Hittelman WN, Lotan R, Nishioka K, Tortolero-Luna G, Richards-Kortum R, Hong WK. Chemoprevention trials in the cervix: design, feasibility, and recruitment, [Review]. Journal of Cellular Biochemistry 1995;23 (Suppl):104-12. [MEDLINE: 8747384].
19. Palan 1988 Palan PR, Basu J, Romney SL. Vaginal hydrolysis of retinyl acetate: increase in plasma retinol and retinol binding protein in women with cervical dysplasias. Biochemical Medicine & Metabolic Biology 1988; 40(3):282-90. [MEDLINE: 3233185].
20. Peng 1986 Peng YM, Alberts DS, Graham V, Surwit EA, Weiner S, Meyskens FL. Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia. Investigational New Drugs 1987;4(3):245-9. [MEDLINE: 3818229].
21. Rui 1997 Rui H. Research and development of cancer chemopreventive agents in China, [Review]. Journal of Cellular Biochemistry 1997;27 (suppl):7-11. [MEDLINE: 9591187].
22. Ruidi 1997 Ruidi C, Aihua D, Peiyu B, Zhongru G, Huazao L, Shifeng S, et al.Chemoprevention of cancer of uterine cervix: a study on chemoprevention of retinamide II from cervical precancerous lesions. Journal of Cellular Biochemistry 1997;28-29 (suppl):140-3. [MEDLINE: 9589359].
23. Sopracordevole 1993 Sopracordevole F, Campagnutta E, Parin A, Scarabelli C. The transretinoic acid in the treatment of cervical intraepithelial neoplasia. The Cervix and the Lower Female Genital Tract 1993; Vol. 11, issue 1:33-4.
24. Surwit 1982 Surwit EA, Graham V, Droegemueller W, Alberts D, Chvapil M, Dorr RT, Davis JR, Meyskens FL Jr. Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions. American Journal of Obstetrics & Gynecology 1982;143(7):821-3. [MEDLINE: 7048932].
25. Weiner 1986 Weiner SA, Surwit EA, Graham VE, Meyskens FL Jr. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy. Investigational New Drugs 1986;4(3):241-4. [MEDLINE: 3818228].
26. Ziegler 1986 Ziegler RG. Epidemiologic studies of vitamins and cancer of the lung, esophagus, and cervix. Advances in Experimental Medicine & Biology 1986;206:11-26. [MEDLINE: 3591517].
27. Altucci 2001 Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nature Reviews Cancer 2001;1(3):181-93. [MEDLINE: 11902573].
28. Behbakht 1996 Behbakht K, DeGeest K, Turyk ME, Wilbanks GD. All-transretinoic acid inhibits the proliferation of cell lines derived from human cervical neoplasia. Gynecologic Oncology 1996;61(1):31-9. [MEDLINE: 8626114].
29. Bollag 1992 Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Annals of Oncology 1992;3(7):513-26. [MEDLINE: 1498071].
30. Brtko 2003 Brtko J, Thalhamer J. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention. Current Pharmaceutical Design 2003;9(25):2067-77. [MEDLINE: 14529416].
31. Choo 1995 Choo CK, Rorke EA, Eckert RL. Retinoid regulation of cell differentiation in a series of human papillomavirus type 16-immortalized human cervical epithelial cell lines. Carcinogenesis 1995;16(2): 375-81. [MEDLINE: 7532115].
32. Follen 2002 Follen M, Vlastos A-T, Meyskens FL Jr, Atkinson N, Schottenfeld D. Why Phase II trials in cervical chemoprevention are negative: what have we learned?. Cancer Causes and Control 2002;13(9):855- 73. [MEDLINE: 12462551].
33. Geisen 1997 Geisen C, Denk C, Gremm B, Baust C, Karger A, Bollag W. High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells. Cancer Research 1997;57(8):1460-67. [MEDLINE: 9108446].
34. Goodman 1984 Goodman DS. Vitamin A and retinoids in health and disease. New England Journal of Medicine 1984;310(16):1023-31. [MEDLINE: 6369133].
35. Grace 2006 Grace VMB, Devaraj NS, Pillai R, Devaraj H. HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level. Gynecologic Oncology 2006;103(1):113-9. [MEDLINE: 16554086].
36. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons Ltd.
37. Hong 1986 Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et al.13-cis-retinoic acid in the treatment of oral leukoplakia. New England Journal of Medicine 1986;315:1501-05. [MEDLINE: 3537787].
38. Hong 1990 Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New England Journal of Medicine 1990;323:795-801. [MEDLINE: 2202902].
39. La Vecchia 1988 La Vecchia C, Decarli A, Fasoli M, Parazzini F, Franceschi S, Gentile A, et al.Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia. Gynecologic Oncology 1988;30(2):187-95. [MEDLINE: 3371743].
40. Liu 1995 Liu T, Soong SJ, Alvarez RD, Butterworth CE Jr. A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical dysplasia progression. Cancer Epidemiology, Biomarkers & Prevention 1995;4(4):373-80. [MEDLINE: 7655333].
41. Lotan 1980 Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochimica et Biophysica Acta 1980;605(1):33-91. [MEDLINE: 6989400].
42. McCance 1988 McCance DJ, Kopan R, Fuchs E, Laimins LA. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proceedings of the National Academy of Sciences of the United States of America 1988;85(19):7169-73. [MEDLINE: 2459699].
43. Mills 1993 Mills CM, Marks R. Adverse reactions to oral retinoids: an update. Drug Safety 1993;9(4):280-90.
44. Nagata 1999 Nagata C, Shimizu H, Higashiiwai H, Sugahara N, Morita N, Komatsu S, et al.Serum retinol level and risk of subsequent cervical cancer in cases with cervical dysplasia. Cancer Investigation 1999;17(4):253-8. [MEDLINE: 10225004].
45. Niles 2000 Niles RM. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer.[see comment]. Nutrition 2000; 16(11-12):1084-9. [MEDLINE: 11118831].
46. Parkin 2006 Parkin DM. The global health burden of infection-associated cancers in the year 2002. International Journal of Cancer 2006;118(12):3030-44. [MEDLINE: 16404738].
47. Potischman 2003 Potischman N, Freudenheim JL. Biomarkers of nutritional exposure and nutritional status: an overview. Journal of Nutrition 2003;133 (3):873S-4S. [MEDLINE: 12612172].
48. Ribeiro 1995 Ribeiro RC, Kushner PJ, Baxter JD, Kushner PJ, Baxter JD. The nuclear hormone receptor gene superfamily. Annual Review of Medicine 1995;46:443-53. [MEDLINE: 7598477].
49. Schimizu 1996 Shimizu H, Nagata C, Komatsu S, Morita N, Higashiiwai H, Sugahara N, et al.Decreased serum retinol levels in women with cervical dysplasia. British Journal of Cancer 1996;73(12):1600-04. [MEDLINE: 8664137].
50. Soprano 1995 Soprano DR, Soprano KJ. Retinoids as teratogens. Annual Review of Nutrition 1995;15:111-32.
51. Sporn 1984 Sporn MB, Roberts AB. Role of retinoids in differentiation and carcinogenesis. Journal of the National Cancer Institute 1984;73(6):1381-7. [MEDLINE: 6595447].
52. Sun 2002 Sun S-Y, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Critical Reviews in Oncology/Hematology 2002;41(1):41-55. [MEDLINE: 11796231].
53. Zanardi 2006 Zanardi S, Serrano D, Argusti A, Barile M, Puntoni M, Decensi A. Clinical trials with retinoids for breast cancer prevention. Endocrine-Related Cancer 2006;13(1):51-68. [MEDLINE: 16601279].